Discovery of anaplastic lymphoma kinase inhibitors from natural product library: A holistic in silico approach-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of anaplastic lymphoma kinase inhibitors from natural product library: A holistic in silico approach

Published:2020-10-13 Issue: Volume: Page:
ISSN:0885-4513
Container-title:Biotechnology and Applied Biochemistry
language:en
Short-container-title:Biotechnology and Applied Biochemistry

Author:

Subburaj Saranyadevi¹,Nagrale Tanvi Anand¹,Khan Mohd. Mustufa¹,James Nivya¹,Karuppasamy Ramanathan¹,Veerappapillai Shanthi¹^ORCID

Affiliation:

1. Department of Biotechnology, School of Bio Sciences and Technology Vellore Institute of Technology Vellore Tamil Nadu 632014 India

Publisher

Wiley

Subject

Process Chemistry and Technology,Drug Discovery,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,General Medicine,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bab.2040

Reference40 articles.

1. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

2. Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

3. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

4. Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer

5. ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non–Small Cell Lung Cancer (NSCLC)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP